COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 965: Articles 9641-9650  | Next

Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children
Dewald, F., Suarez, I., Johnen, R., Grossbach, J., Tovar, R., Steger, G., Joachim, A., Rubio, G., Fries, M., Behr, F., Kley, J., Lingnau, A., Kretschmer, A., Gude, C., Flores, G., del Valle, D., Hernandez, A., Cerino, J., Hernandez, A., Quinones, J., Schega, K., Linne, V., Junker, L., Wunsch, M., Heger, E., Knops, E., Di Cristanziano, V., Meyer, M., Huenseler, C., Weber, L. T., Lueers, J., Quade, G., Wisplinghoff, H., Tiemann, C., Zotz, R., Jomaa, H., Pranada, A., Herzum, I., Cullen, P., Schmitz, F., Philipsen, P., Kirchner, G., Knabbe, C., Hellmich, M., Buess, M., Wolf, A., Kossow, A., Niessen, J., Jeworutzki, S., Schraepler, J., Laessig, M., Doetsch, J., Faetkenheuer, G., Kaiser, R., Beyer, A., Rybniker, J., Klein, F.
10.1101/2022.02.04.22270304 — Posted: 2022-02-06
Effects of socio-economic factors on elementary school student COVID-19 infections in Ontario, Canada
Srivastava, P., Lau, N. T. T., Ansari, D., Thampi, N.
10.1101/2022.02.04.22270413 — Posted: 2022-02-06
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
Colosi, E., Bassignana, G., Barrat, A., Lina, B., Vanhems, P., Bielicki, J., Colizza, V.
10.1101/2022.02.04.22270473 — Posted: 2022-02-06
The GLasses Against transmission of SARS-CoV-2 in the communitY (GLASSY) trial: A pragmatic randomized trial (study protocol)
Fretheim, A., Hemkens, L. G., Helleve, A., Elstrom, P., Elgersma, I. H., Kacelnik, O.
10.1101/2022.02.04.22270120 — Posted: 2022-02-06
Comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections: A time-varying cohort analysis using trial emulation in the Virus Watch community cohort
Nguyen, V., Yavlinsky, A., Beale, S., Hoskins, S. J., Lampos, V. J., Braithwaite, I., Byrne, T. E., Fong, W. L. E., Fragaszy, E., Geismar, C., Kovar, J., Navaratnam, A. M. D., Patel, P., Shrotri, M., Weber, S., Hayward, A., Aldridge, R. W.
10.1101/2022.02.04.22270479 — Posted: 2022-02-06
Wastewater Surveillance of U.S. Coast Guard Installations and Seagoing Military Vessels to Mitigate the Risk of COVID-19 Outbreaks
Hall, G. J., Page, E. J., Rhee, M., Hay, C. M., Krause, A., Langenbacher, E., Ruth, A., Grenier, S., Duran, A. P., Kamara, I., Iskander, J. K., Thomas, D. L., Bock, E., Porta, N., Pharo, J., Osterink, B. A., Zelmanowitz, S., Fleischmann, C., Liyanage, D., Gray, J. P.
10.1101/2022.02.05.22269021 — Posted: 2022-02-06
A scalable pipeline for SARS-CoV-2 replicon construction based on de-novo synthesis
Berkyurek, A. C., Lee, E., Weissbrod, O., Rasnic, R., Falciatori, I., Chen, S., Erlich, Y.
10.1101/2022.02.05.478644 — Posted: 2022-02-05
SARS-CoV-2 and influenza co-infection throughout the COVID-19 pandemic: An assessment of co-infection rates and cohort characterization
Pawlowski, C., Silvert, E., O'Horo, J. C., Lenehan, P. J., Challener, D. W., Gnass, E., Murugadoss, K., Ross, J., Speicher, L., Geyer, H., Venkatakrishnan, A. J., Badley, A., Soundararajan, V.
10.1101/2022.02.02.22270324 — Posted: 2022-02-05
A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021
Adamson, J. P., Smith, C., Pacchiarini, N., Connor, T. R., Wallsgrove, J., Coles, I., Frost, C., Edwards, A., Moore, C., Sinha, J., Perrett, S., Craddock, C., Sawyer, C., Waldram, A., Barrasa, A., Thomas, D. R., Daniels, P., Lewis, H.
10.1101/2022.02.02.22269960 — Posted: 2022-02-05
Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam
Dang, A. D., Vu, T. D., Vu, H. H., Ta, V. T., Pham, A. T. V., Dang, M. T. N., Le, B. V., Duong, T. H., Nguyen, D. V., Lawpoolsri, S., Chinwangso, P., McLellan, J. S., Hsieh, C.-L., Garcia-Sastre, A., Palese, P., Sun, W., Martinez, J. L., Gonzalez-Dominguez, I., Slamanig, S., Carreno, J. M., Tcheou, J., Krammer, F., Raskin, A., Vu, H. M., Tran, T. C., Nguyen, H. M., Mercer, L. D., Raghunandan, R., Lal, M., White, J. A., Hjorth, R., Innis, B. L., Scharf, R.
10.1101/2022.02.01.22270253 — Posted: 2022-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).